Aegon - Intraday - We look to Sell a break of 4.578 (stop at 4.757) Although the bulls are in control, the stalling positive momentum indicates a turnaround is possible. The primary trend remains bearish. Trading within a Corrective Channel formation. A break of the recent low at 4.585 should result in a further move lower. Trading has been mixed and...
Aegon - Intraday - We look to Sell at 4.898 (stop at 5.021) 4.900 continues to hold back the bulls. The previous swing high is located at 4.878. Bespoke resistance is located at 4.900. 4.916 has been pivotal. Preferred trade is to sell into rallies. Resistance could prove difficult to breakdown. Our profit targets will be 4.604 and 4.544 Resistance:...
Downtrend is finished. RSI is suitable for an uptrend. Cup & handle formation got the confirmation, so? Ready to go. TP 4.25 SL 1.98 or follow blue trend line.
This is my first signal on this platform. Please let me know what you guys think and also substantiate your opinion. Thank you
After a good start at the beginning on 3 august, there was a buy signal on the bottom indicator RSI3M3 . Until 12 august the price was rising very rapidly and gave a good return for all investors. On the day that the earnings were published the price of this stock plunged back to the price of begin august and created a sell signal. The price is beneath the...
Hey All, take a look at the chart pattern on AGN, seems to be really consistent, swoosh, then crash then consolidate, swoosh then crash then consolidate. Have i been looking at too many charts? Seeing things? lol, its a possibility, but it looks to me like we are starting a swoosh down right now after coming off highs at AGN. Either that or we are about to...
Another stock getting some attention during COVD. These guys have a good model, basically standing on the shoulders of others and reworking their formulas to make their own Vaccines. There is potential for this company post covid, provided they get a vaccine going. I took a small stake in this company based on Pre Covid activities. IF they do end up getting a...
This big Pharma has been on the decline since 2015. I see it is in the top of the channel currently. Good opportunity to short to the bottom of the channel, especially with the general market declining.
WXY potential that i see playing out
My Sell got triggered 152.81 ( Below 618 level of 153.8) TP1 - 147 TP2 - 143.3
AGN is on a short confirmed uptrend for right now. This stock will get high, to about 168.50 then resistance levels will be hit at that point cover the gains rinse-n-repeat.
It seems to be pretty close or already has finished the (1) and (2). If this label is not correct, at least a 5 wave down is clear. Watch for a bounce soon.
www.tradingview.com Stock oversold. As always. Target is floating and not set . If the trade is successful, I will close once it hit's SMA200 again.
Probability of a new tren. Buying 300 shares.
Allergan stock has been volatile since the merger with Pfizer was abandoned due to Tax Inversion laws back in April 2016. After a April-August Pattern was successful in predicting a downtrend, there has been an emergence of a bullish pattern. Looking purely at technical's I see the stock hitting the 0.236 fib retracement before the earnings call scheduled for 2nd...
With broad market volatility ebbing, the place to sell premium is with earnings plays for now. Next week, look to put on options plays shortly before the earnings announcement to capitalize on post-announcement volatility contraction. This little fellahs currently look best for plays: LC: 5/9 (Monday) after market close. Due to the price of the underlying,...
Due to worse than expected ER, and lowered guidance, and top of all failed $AGN acquisition, it is very possible that $VRX is going to $90-$100 price level. Company is not profitable and even if their international profits rise (mostly Russia and Europe), there are problems in creating sustainable growth.